Search

everythinglearnresearchcommunity

for

Search:↓

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Some cancer treatments can cause permanent hair loss.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Certain chemotherapy drugs can cause permanent hair loss in stem cell transplant patients.

Patients often experience long-lasting changes to their hair after stem cell transplants.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Some chemotherapy can cause permanent hair loss.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Some breast cancer chemotherapy can cause permanent hair loss.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.